Annuity Payments in Brazil: New Regulations

The Braz. Patent Office published on December 19, 2023 new rules regarding the payment and settlement of annuities, in order to enable … Annuity Payments in Brazil: New Regulations

The Braz. Patent Office published on December 19, 2023 new rules regarding the payment and settlement of annuities, in order to enable … Annuity Payments in Brazil: New Regulations

ANVISA’s new Regulatory Agenda 2024-2025 (RA 24/25) was approved and published on the Official Gazette on December 18th. The Joint Ordinance No. … 2024-2025 Regulatory Agenda Has Been Approved by the Brazilian FDA

As recently reported, the BRPTO announced a series of new guidelines regarding the processing of patent, trademark and industrial design applications. Check … Industrial Design Registration: new BRPTO opinion on the scope of appeal

Last Wednesday, December 13, 2023, the Brazilian National Data Protection Authority (“ANPD”) published the first Priority Themes Map (“MPT”) through Resolution CD/ANPD No. … ANPD releases the Priority Themes Map for the 2024-2025 biennium

On December 12, 2023, the Brazilian PTO published (BPTO) Opinion 17/2003/CGPI/PFE-INPI/PGF/AGU in response to the inquiry submitted by the General Coordination of Resources … New rule on the devolutive effect in the analysis of appeals against the refusal of trademark registration: what changes

On Tuesday, December 12, 2023, the BRPTO published new rules that limit applicants’ acts in the administrative process for granting patents. At the … The BRPTO ruled that it is not possible to amend a patent application during the appeal phase

The number of Brazilians using medicinal cannabis-based medications increased by approximately 165% in one year, representing a jump from 188,000 to 430,000 … Increase in Patients Using Medicinal Cannabis and Its Consequences

The Brazilian Patent and Trademark Office (BPTO) has just announced that it will now order the distribution and technical examination of patent … Patent applications: BPTO shifts priority to examination request dates for faster decisions in Brazil

Starting February 6, 2024, generic and branded-generic (“similar”) drugs will be allowed to have different labels than their respective standard labels with … Anvisa approves skinny labeling practice in Brazil

The enactment of Law No. 14,597/2023 (known as General Sports Law – GSL) in June of this year marks a milestone for … The protection of IP rights in the new Brazilian sports law